Samsung Bioepis commences clinical trial of its 10th biosimilar
이 글자크기로 변경됩니다.
(예시) 가장 빠른 뉴스가 있고 다양한 정보, 쌍방향 소통이 숨쉬는 다음뉴스를 만나보세요. 다음뉴스는 국내외 주요이슈와 실시간 속보, 문화생활 및 다양한 분야의 뉴스를 입체적으로 전달하고 있습니다.
A trial protocol was published on ClinicalTrials.gov on Feb. 26, the company said on Tuesday. The Phase 1 trial started in 201 healthy volunteers in France last month with an aim of demonstrating the drug’s pharmacokinetics, safety and immunogenicity.
The original drug of SB17, which is marketed by U.S. Johnson & Johnson (Janssen), is a prescription autoimmune disease medicine used to treat patients with psoriasis, psoriatic arthritis, Crohn's disease, and ulcerative colitis. Stelara’s global sales came to $7.7 billion last year.
Founded in 2012 as a joint venture between Korean biopharmaceutical company Samsung Biologics under Samsung Group and its U.S. partner Biogen, Samsung Bioepis has successfully launched three autoimmune disease and two oncology biosimilars globally.
This is its 10th biosimilar’s clinical trial Samsung Bioepis, and additional therapeutic areas in the pipeline include eye diseases, blood diseases, and skeletal diseases, according to the company.
[ⓒ Maeil Business Newspaper & mk.co.kr, All rights reserved]
Copyright © 매일경제 & mk.co.kr. 무단 전재, 재배포 및 AI학습 이용 금지
- Memory super cycle may last longer this time, given the rise in spot movements - Pulse by Maeil Business News Korea
- Seoul packages $17 billion Covid-19 aid in first budgetary increase this year - Pulse by Maeil Business News Korea
- Samsung C&T scores $2 bn LNG expansion contract from QP - Pulse by Maeil Business News Korea
- Thriving food delivery market in Korea surges by 80% to $15.5 bn last year - Pulse by Maeil Business News Korea
- NPS may have to exit by another $14 bn from local stock market this year - Pulse by Maeil Business News Korea
- 강경준, 상간남 피소…사랑꾼 이미지 타격 [MK픽] - 스타투데이
- 아파트 낙찰가율 90% 돌파…빌라는 ‘눈물’ [감평사의 부동산 현장진단]
- “결혼 전제로 열애”…에일리 연인은 ‘솔로지옥’ 최시훈이었다[공식입장] - MK스포츠
- 이찬원, 이태원 참사에 "노래 못해요" 했다가 봉변 당했다 - 스타투데이
- 양희은·양희경 자매, 오늘(4일) 모친상 - 스타투데이